Rapid genetic testing targets advanced prostate cancer patients for new treatments

by

A rapid genetic testing model for patients with advanced prostate cancer can more quickly identify those with “actionable” gene variants eligible for newer targeted therapies, reports a clinical trial in The Journal of Urology.

Leave A Comment

Your email address will not be published. Required fields are marked *